Last reviewed · How we verify
NCT03107312: StikoSero
Bioarray for the Serological Assessment of Immunity Against Vaccine-preventable Infections
trial testing Single blood sample collection in Immunization; Infection in 900 participants. Status unknown.
31 March 2018
Quick facts
| Lead sponsor | Jena University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 900 |
| Start date | 1 April 2017 |
| Primary completion | 31 March 2018 |
| Estimated completion | 31 March 2018 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Single blood sample collection
Conditions studied
- Immunization; Infection — all drugs for Immunization; Infection →
Sponsor
Jena University Hospital
Who can join
18 and older, any sex, with Immunization; Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recent observations in Germany revealed above-average high proportions of refugees affected by infectious diseases of public health significance. Scrutiny of the vaccination status showed sizeable presence of seronegative subjects, with conspicuously higher prevalence among children and adolescents, thus indicating urgent necessity of i) rapid identification of carriers of vaccine-preventable diseases and ii) adjustment of protection against such infections to European Standards. Rapid immune status check needs comprehensive diagnostic tool permitting simultaneous assessment of seropositivity. Validation of such tools requires comparisons of the immune status of subjects with known vaccination history with that of migrants with incomplete or missing health and vaccination records.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03107312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Immunization; Infection
Currently open trials in the same condition.
- NCT07128095 — COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise · recruiting
- NCT05947071 — High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients · Phase 2 · recruiting
- NCT05859490 — Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination · Phase 1, PHASE2 · recruiting
- NCT05774093 — Evaluation of COVID-19 Immune Barrier and Reinfection Risk · recruiting
- NCT05215327 — High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients · Phase 2 · recruiting
Other Jena University Hospital trials
Trials by the same sponsor.
- NCT06355050 — Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer · not yet recruiting
- NCT06749483 — The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units? · recruiting
- NCT06765551 — AI Based Muscular Ultrasound to Assess Intensive Care Unit-acquired Weakness · recruiting
- NCT06539377 — Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma · NA · not yet recruiting
- NCT07428226 — Serum Bile Acid Profiles in Patients With Intrahepatic Cholestasis of Pregnancy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03107312 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jena University Hospital
- Last refreshed: 15 May 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03107312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing